20-37943993-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000373461.9(VSTM2L):c.355G>A(p.Val119Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000007 in 1,428,596 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 28)
Exomes 𝑓: 7.0e-7 ( 0 hom. )
Consequence
VSTM2L
ENST00000373461.9 missense
ENST00000373461.9 missense
Scores
2
5
9
Clinical Significance
Conservation
PhyloP100: 4.73
Genes affected
VSTM2L (HGNC:16096): (V-set and transmembrane domain containing 2 like) Predicted to enable cell-cell adhesion mediator activity. Involved in negative regulation of neuron apoptotic process. Located in cytoplasm and extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1320323).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSTM2L | NM_080607.3 | c.355G>A | p.Val119Met | missense_variant | 4/4 | ENST00000373461.9 | NP_542174.1 | |
VSTM2L | XM_011528530.2 | c.304G>A | p.Val102Met | missense_variant | 3/3 | XP_011526832.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSTM2L | ENST00000373461.9 | c.355G>A | p.Val119Met | missense_variant | 4/4 | 1 | NM_080607.3 | ENSP00000362560.4 | ||
VSTM2L | ENST00000448944.1 | c.304G>A | p.Val102Met | missense_variant | 3/3 | 3 | ENSP00000406537.1 | |||
VSTM2L | ENST00000373459.4 | c.134G>A | p.Gly45Asp | missense_variant | 2/2 | 3 | ENSP00000362558.4 |
Frequencies
GnomAD3 genomes Cov.: 28
GnomAD3 genomes
Cov.:
28
GnomAD4 exome AF: 7.00e-7 AC: 1AN: 1428596Hom.: 0 Cov.: 45 AF XY: 0.00000142 AC XY: 1AN XY: 704790
GnomAD4 exome
AF:
AC:
1
AN:
1428596
Hom.:
Cov.:
45
AF XY:
AC XY:
1
AN XY:
704790
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 28
GnomAD4 genome
Cov.:
28
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.355G>A (p.V119M) alteration is located in exon 4 (coding exon 4) of the VSTM2L gene. This alteration results from a G to A substitution at nucleotide position 355, causing the valine (V) at amino acid position 119 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;N
PROVEAN
Benign
N
REVEL
Benign
Sift
Pathogenic
D
Sift4G
Benign
T
Vest4
MutPred
Loss of catalytic residue at L50 (P = 0.1187);
MVP
ClinPred
D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.